BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19269841)

  • 1. Images in cardio-thoracic surgery: Novacor left ventricular assist device inflow valve endocarditis.
    Gazzoli F; Grande AM; Pagani F; Viganò M
    Eur J Cardiothorac Surg; 2009 May; 35(5):910. PubMed ID: 19269841
    [No Abstract]   [Full Text] [Related]  

  • 2. Does the type of ventricular assisted device influence survival, infection, and rejection rates following heart transplantation?
    Shuhaiber J; Hur K; Gibbons R
    J Card Surg; 2009; 24(3):250-5. PubMed ID: 19438776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanical and biologic analysis of a 1,512-day-long implanted Novacor left ventricular assist device.
    Gambino A; di Marco F; Feltrin G; Toscano G; Gerosa G; Angelini A; Thiene G
    J Heart Lung Transplant; 2006 Apr; 25(4):492-4. PubMed ID: 16563987
    [No Abstract]   [Full Text] [Related]  

  • 4. Driveline insulation as a conduit for left ventricular assist device pocket infection.
    Pinninti M; Thohan V; Sulemanjee NZ
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):e135-6. PubMed ID: 24755334
    [No Abstract]   [Full Text] [Related]  

  • 5. Left ventricular assist device outflow cannula obstruction by the rare environmental fungus Myceliophthora thermophila.
    Weitzel N; Puskas F; Cleveland J; Levi ME; Seres T
    Anesth Analg; 2009 Jan; 108(1):73-5. PubMed ID: 19095833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular assist device application with the intermediate use of a membrane oxygenator as a bridge to pediatric heart transplantation.
    Garcia-Guereta L; Cabo J; de la Oliva P; Villar MA; Bronte LD; Goldman L; Hübler M
    J Heart Lung Transplant; 2009 Jul; 28(7):740-2. PubMed ID: 19560705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prosthetic valve endocarditis caused by Scedosporium apiospermum.
    Verghese S; Padmaja P; Chellamma MT; Leelavathy S; Nayar P
    Indian J Med Microbiol; 2005 Oct; 23(4):264-6. PubMed ID: 16327126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonvalvular cardiovascular device-related infections.
    Baddour LM; Bettmann MA; Bolger AF; Epstein AE; Ferrieri P; Gerber MA; Gewitz MH; Jacobs AK; Levison ME; Newburger JW; Pallasch TJ; Wilson WR; Baltimore RS; Falace DA; Shulman ST; Tani LY; Taubert KA
    Clin Infect Dis; 2004 Apr; 38(8):1128-30. PubMed ID: 15095218
    [No Abstract]   [Full Text] [Related]  

  • 9. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices.
    Hannan MM; Husain S; Mattner F; Danziger-Isakov L; Drew RJ; Corey GR; Schueler S; Holman WL; Lawler LP; Gordon SM; Mahon NG; Herre JM; Gould K; Montoya JG; Padera RF; Kormos RL; Conte JV; Mooney ML;
    J Heart Lung Transplant; 2011 Apr; 30(4):375-84. PubMed ID: 21419995
    [No Abstract]   [Full Text] [Related]  

  • 10. Current concepts in the diagnosis and management of left ventricular assist device infections.
    Nienaber J; Wilhelm MP; Sohail MR
    Expert Rev Anti Infect Ther; 2013 Feb; 11(2):201-10. PubMed ID: 23409825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term left-ventricular-assist-device therapy is here to stay.
    Yacoub MH; Miller LW
    Nat Clin Pract Cardiovasc Med; 2008 Feb; 5(2):60-1. PubMed ID: 18043595
    [No Abstract]   [Full Text] [Related]  

  • 12. Continuous-flow left ventricular assist device.
    Landzaat LH; Sinclair CT; Rosielle DA
    N Engl J Med; 2010 Mar; 362(12):1149; author reply 1149. PubMed ID: 20335596
    [No Abstract]   [Full Text] [Related]  

  • 13. Left ventricular assist devices. Preface.
    Elefteriades JA; Botta DM
    Cardiol Clin; 2011 Nov; 29(4):xiii-xiv. PubMed ID: 22062219
    [No Abstract]   [Full Text] [Related]  

  • 14. Massive occult infection of a left ventricular assist device with Candida albicans.
    Sabashnikov A; Mohite PN; Zych B; Popov AF; Garcia D; Simon AR
    Artif Organs; 2013 Jun; 37(6):582-3. PubMed ID: 23638703
    [No Abstract]   [Full Text] [Related]  

  • 15. From apheresis for the preparation of ventricular assist devices and transplantation to combination therapy of apheresis and ventricular assist devices for myocardial repair.
    Nosé Y
    Artif Organs; 2009 Jan; 33(1):1-2. PubMed ID: 19178435
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanical assist for heart failure. Left ventricular assist devices offer a new lease on life for some people with severe heart failure.
    Harv Heart Lett; 2008 Jan; 18(5):4-5. PubMed ID: 18293530
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of multiple left ventricular assist device failures in a patient.
    Myers TJ; Palanichamy N; La Francesca S; Odegaard PA; Gregoric ID; Frazier OH
    J Heart Lung Transplant; 2007 Jan; 26(1):98-100. PubMed ID: 17234525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous flow rotary left ventricular assist device: mechanical circulatory support 2.0.
    Eisen HJ; Hankins SR
    J Am Coll Cardiol; 2009 Jul; 54(4):322-4. PubMed ID: 19608029
    [No Abstract]   [Full Text] [Related]  

  • 19. Invited commentary.
    Esmore DS
    Ann Thorac Surg; 2010 Oct; 90(4):1277. PubMed ID: 20868827
    [No Abstract]   [Full Text] [Related]  

  • 20. Left ventricular assist device placement in a patient with end-stage heart failure and human immunodeficiency virus.
    Fieno DS; Czer LS; Schwarz ER; Simsir S
    Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):919-20. PubMed ID: 19706718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.